Interventional Cardiologist @ISIC_Official/ food and comedy enthusiast/ 3rd gen. Chinese-Indonesian🇲🇨/ FIHA,FAsCC,FAPSC,FESC,FAPSIC,FACC,FSCAI
Lampung, Indonesia
Joined May 2022
- Tweets3.5K
- Following571
- Followers416
- Likes9.3K
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
📢 New in the European Heart Journal
#EACVI/@escardio Council of Cardiology Practice Clinical Consensus Statement on cardiac CT in everyday practice.
🫀 This is particularly for the non-CT expert — a practical guide to help clinicians understand:
🔍 What can cardiac CT detect and assess?
đź“Š How can CT help with patient risk stratification?
đź“ť What clinical question/information should be included in the referral?
đź“„ What should you look for in the CT report?
And importantly, cardiac CT is much more than coronary imaging — with applications across valvular disease, cardiomyopathies, cardiac masses, the great vessels and congenital heart disease.
The aim: to make cardiac CT findings easier to understand and translate into everyday clinical decision-making and patient care.
🔗 academic.oup.com/eurheartj/a…
#CardiacCT #CardiacImaging #Cardiology #EACVI #ESC
@gpontone1 @StefanoNistri @drkharabish @JRodriPalomares @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503 @ehj_ed
academic.oup.com/eurheartj/a…
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
⚠️ A wire left behind for over a year in the internal carotid artery. When percutaneous retrieval risks vascular injury, open surgery may be the safer answer. This case shows successful removal with carotid patch repair.
jvscit.org/article/S2468-428…
#CarotidSurgery #Foreignbody
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
DECISION MAKING IN COMPLEX CORONARY ATHEROSCLEROSIS AND PHOTON COUNTING CT
Decision making in coronary science is complex.
Having the precise diagnosis, the correct framework where we are going to plan an intervention (or the information on which we decide to post-pone or not proceed for the intervention), all the things required to make the right decision is of paramount importance.
Dual Source Photon Counting CT allows to compress in one single diagnostic step basically all the diagnostically and technically relevant information to make these decision comfortably and properly.
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
In the double-blind, randomized FITTER trial, 150 patients with acute coronary syndrome and relevant non-culprit lesions received evolocumab or placebo for 12 weeks in addition to high-intensity statin therapy. PCSK9 inhibition did not produce additional short-term improvements in plaque lipid content, plaque volume, or coronary physiology.
Original article: eurointervention.pcronline.c…
Editorial: eurointervention.pcronline.c…
@hect2701 @RGeuns @NielsRoyen @robebyrne
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
We are deeply saddened by the passing of Professor David Taggart of Oxford University, a giant in cardiovascular surgery.
We were honored to recognize him with the Master of the Masters Award at TCTAP 2026.
His legacy will continue to inspire us. May he rest in peace.
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
IVUS tip for PE thrombectomy: Once you start using IVUS, it’s hard to go back.
Case by @TheNarulaSeries, severe renal failure (Cr 14) made CT a poor option, so the entire PE thrombectomy was performed with zero contrast using IVUS.
Why IVUS?
• Watch thrombus resolve in real time
• Know when the vessel tapers to avoid advancing a large device too far
• Maintain an additional access site if MCS becomes necessary #CardioX
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
In a post-hoc analysis of 2 RCTs in patients with a single CTO, PCI achieved higher improvements in QoL, angina frequency, and SAQ summary score than OMT, but CV death/MI was non-significantly higher in the PCI group (5.1 vs 2.7% P=0.17) sciencedirect.com/science/ar…
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
In focal disease, PCI resulted in greater placebo-controlled improvement of symptoms compared with diffuse disease. Physiological patterns of disease may be useful to guide treatment decision making with PCI for symptom relief sciencedirect.com/science/ar…
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
From the latest issue: Li and colleagues share a unique case of intravenous pyogenic granuloma in the great saphenous vein.
#GSV #Vascular
🔗 doi.org/10.1177/1358863X2513…
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
🦵 The ulcer was on the right leg. The problem was on the left.
A patient with C6 venous disease achieved complete ulcer healing after treatment of left iliac vein compression combined with right GSV ablation.
👉 jvscit.org/article/S2468-428…
#VenousDisease #MayThurnerSyndrome
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
Not all venous reflux is saphenous.
This study shines a light on the sartorial vein plexus—an underrecognized source of reflux.
Accurate diagnosis and targeted treatment were associated with excellent 1-year clinical outcomes.
jvsvenous.org/article/S2213-…
#JVSVL #Venous #DUS
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
🫀 Could #SGLT2i become the first disease-modifying therapy for #RHD? Beyond glucose-lowering, their anti-inflammatory, antifibrotic, & endothelial-protective effects may help slow valvular damage and remodeling. Clinical trials needed! jacc.org/doi/10.1016/j.jacas… #JACCAsia @PPibarot
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
A review of the effects of marathon running on the heart
bmjopensem.bmj.com/content/1…
including release of blood biomarkers cardiac troponin, NT-proBNP without known clinical significance
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
Chrissy van Wely, MD; Rens J. Oosterveld, MD; Lieke C.D. Brugman, MSc; Ozan Yazar, MD; & Lee H. Bouwman, MD, offer practical guidance outlining the benefits, limitations, & technical considerations of using OCT in BTK treatment. evtoday.com/articles/2026-ma…
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
Double barrel LAD following guideliner-induced dissection.
Teaching point: Don’t inject through GL, if the pressures are damped.
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
Supplementation with #Menaquinone7 for 2 years modestly slowed progression of #CoronaryArteryCalcification in patients with coronary artery disease, with no major adverse effects.
ja.ma/4e0kpBj
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
🤔 Have you heard of the "Woundosome" concept?
You can learn all about it in the upcoming online journal club webinar! Our special guest, Lorenzo Patrone, will walk us through it and together with the audience, we will discuss the following paper: Patrone L et al. 'The “Woundosome” Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia.'
Join this free webinar
10th of June at 18
zoom.us/launch/jc/9400516312…
@vascularIR
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
Would you ask a butcher for bread?
Patients with CTOs are often told that collaterals are enough, PCI is too risky, or the artery can't be opened. Patients deserve to understand all available options.
Consider referring for a second opinion before declaring treatment impossible.
🤖 Made with AI
Erwin Mulia, FIHA,FESC,FACC,FAPSIC,FSCAI retweeted
We know that aspirin can often be safely discontinued after PCI, provided it is not stopped too early. But how early is too early?
In this meta-analysis of 11 RCTs including 37,443 PCI patients—now incorporating the recent NEOMINDSET and TARGET-FIRST trials—we found that aspirin discontinuation at either ≤3 months or ≤1 month, followed by P2Y12 inhibitor monotherapy, reduced bleeding without increasing MACE compared with 12-month DAPT.
The key finding is that while discontinuation within the first month may provide an additional bleeding benefit, it appears to come at the cost of increased stent thrombosis, particularly in patients at higher ischaemic risk.
academic.oup.com/eurheartj/a…
👍🏻👍🏻👍🏻 #TCTAP2026
đź“°News Article Updates from #TCTAP2026
The conversation continues on some of the most debated topics in PCI, from treating vulnerable plaques and differentiating DCB technologies to optimizing left main PCI with IVUS guidance and MSA targets.
🔗Read Now: summitmd.com/html/conference…
